ABSTRACT
Background In the Netherlands, the number of mpox cases started declining before mpox vaccination was initiated. Most cases were men who have sex with men (MSM). We investigated whether the decline in mpox could be attributed to infection-induced immunity or behavioural adaptations.
Methods We developed a transmission model and accounted for possible behavioural adaptations: less casual partners and shorter time until MSM with mpox refrain from sexual contacts.
Results Without behavioural adaptations, the peak in modelled cases matched observations, but the decline was less steep than observed. With behavioural adaptations in the model, we found a decline of 16-18% in numbers of casual partners in June and 13-22% in July 2022. Model results showed a halving of the infectious period before refraining from sex. When vaccination started, 57% of MSM with very high sexual activity in the model had been infected. Model scenarios revealed that the outbreak could have waned by November 2022 even without vaccination.
Conclusions The limited duration of the mpox outbreak in the Netherlands can be ascribed to infection- induced immunity among MSM with high sexual activity levels. The subsequent decline was accelerated by behavioural adaptations. Immunity among those most sexually active is essential to impede mpox resurgence.
Short summary Modelling study shows that the decline in mpox cases among MSM in the Netherlands was due to infection-induced immunity among those with high sexual activity levels, but was accelerated by behavioural adaptions. The outbreak could have faded even without vaccination.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Fuminari Miura received funding from Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number 20J00793). No other funding was received specific for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The source data on mpox cases were openly available when the study started. They can be freely and openly accessed on the website of the National Institute of Public Health and the Environment (RIVM) of the Netherlands: https://www.rivm.nl/en/mpox. All other data (used as input to inform model parameters; and data obtained as model output) are available upon reasonable request to the authors
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Availability of data and materials: The data for the numbers of daily mpox cases in the Netherlands described in this study can be freely and openly accessed on the website of the National Institute of Public Health and the Environment (RIVM) of the Netherlands: https://www.rivm.nl/en/mpox. The data from the “COVID-19, Sex, and Intimacy Survey” and the survey “Monkeypox: a new challenge for your sex life” are third party data and are not freely available; enquiries for data access can be addressed to Prof. J. de Wit. Description of data from the “COVID-19, Sex, and Intimacy Survey” have been published in Xiridou et al. Sex Transm Diseas 2020; 49:145-153. The code for the model analyses is available at https://github.com/rivm-syso/fadingmpoxoutbreak.
The analyses were repeated with expanded ranges of the uncertain parameters. The figures and tables have been updated. The section Results and some parts of Methods have been updated.
Data Availability
The data for the numbers of daily mpox cases in the Netherlands described in this study can be freely and openly accessed on the website of the National Institute of Public Health and the Environment (RIVM) of the Netherlands: https://www.rivm.nl/en/mpox. All other data (used as input to inform model parameters; and data obtained as model output) are available upon reasonable request to the authors
